| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.4 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |